Scientific References:

  1. Candela, M. et al. Interaction of probiotic Lactobacillus and Bifidobacterium strains with human intestinal epithelial cells: adhesion properties, competition against enteropathogens and modulation of IL-8 production. Int. J. Food Microbiol. 125, 286–292 (2008).
  2. Fukuda, S. et al. Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature 469, 543–547 (2011).
  3. Devillard, E., McIntosh, F. M., Duncan, S. H. & Wallace, R. J. Metabolism of linoleic acid by human gut bacteria: different routes for biosynthesis of conjugated linoleic acid. J. Bacteriol. 189, 2566–2570 (2007)
  4. Bäckhed, F.et al.The gut microbiota as an environmental factor that regulates fat storage. Proc. Natl Acad. Sci. USA 101, 15718–15723 (2004)
  5. Olszak, T. et al. Microbial exposure during early life has persistent effects on natural killer T cell function. Science 336, 489–493 (2012)
  6. Forsythe P, Kunze WA, Bienenstock J. On communication between gut microbes and the brain. Curr Opin Gastroenterol. 2012;28:557-562.
  7. Carvalho BM, Saad MJ. Influence of gut microbiota on subclinical inflammation and insulin resistance. Mediators Inflamm. 2013:986734.
  8. Parnell JA, Reimer RA Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults. Am J Clin Nutr 2009;89:1751–9.
  9. Patrice D. Cani,* Melania Osto, Lucie Geurts, and Amandine Everard Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity. Gut Microbes. 2012 July 1; 3(4): 279–288.
  10. Murphy EF, Cotter PD, Hogan A, et al. Divergent metabolic outcomes arising from targeted manipulation of the gut microbiota in diet-induced obesity. Gut. 2013;62:220-226.
  11. Qin, J. et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464, 59–65 (2010).
  12. The Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature 486, 207–214 (2012).
  13. Jalanka-Tuovinen J, Salonen A, Nikkilä J, et al. Intestinal microbiota in healthy adults: temporal analysis reveals individual and common core and relation to intestinal symptoms. PLoS One. 2011;6:e23035.
  14. Lozupone CA, Stombaugh JI, Gordon JI, Jansson JK, Knight R. Diversity, stability and resilience of the human gut microbiota. Nature. 2012 Sep 13;489(7415):220-30.
  15. Yatsunenko, T. et al. Human gut microbiome viewed across age and geography. Nature 486, 222–227 (2012)
  16. De Filippo, C. et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc. Natl Acad. Sci. USA 107, 14691–14696 (2010).
  17. Qin, J. et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464, 59–65 (2010)
  18. Manichanh, C.et al.Reduced diversity of faecal microbiota in Crohn’s disease revealed by a metagenomic approach. Gut 55, 205–211 (2006)
  19. Lepage, P.et al.Twin study indicates loss of interaction between microbiota and mucosa of patients with ulcerative colitis. Gastroenterology 141, 227–236 (2011)
  20. Logan AC, Rao, AV, Irani D.  Chronic fatigue syndrome: lactic acid bacteria may be of therapeutic value.  Medical hypotheses (2003) 60(6); 915-923
  21. Claesson, M. J. et al. Gut microbiota composition correlates with diet and health in the elderly. Nature 488, 178–184 (2012)
  22. Le Chatelier E, et al. Richness of human gut microbiome correlates with metabolic markers.Nature. 2013 Aug 29;500(7464):541-6.
  23. Lee YK, Menezes JS, Umesaki Y, Mazmanian SK. Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A. 2011;108 Suppl 1:4615-4622.
  24. Wang Y, Kasper LH.The role of microbiome in central nervous system disorders. Brain Behav Immun. 2013 Dec 25.
  25. Vaarala O, Atkinson MA, Neu J. The "perfect storm" for type 1 diabetes: the complex interplay between intestinal microbiota, gut permeability, and mucosal immunity. Diabetes. 2008;57:2555-2562.
  26. Hara N, Alkanani AK, Ir D, et al. The role of the intestinal microbiota in type 1 diabetes. Clin Immunol. 2013;146:112-119.
  27. Dicksved, J. et al. Molecular analysis of the gut microbiota of identical twins with Crohn’s disease. ISME J. 2, 716–727 (2008).
  28. Lupton, J. R. Microbial degradation products influence colon cancer risk: the butyrate controversy. J. Nutr. 134, 479–482 (2004).
  29. Xiao S, Zhao L.Gut microbiota-based translational biomarkers to prevent metabolic syndrome via nutritional modulation. FEMS Microbiol Ecol. 2013 Nov 12.
  30. Tang WH, Wang Z, Levison BS, et al. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N Engl J Med. 2013;368:1575-1584.
  31. Scher JU, Sczesnak A, Longman RS, et al. Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis. eLife. 2013;2:e01202.
  32. Opal SM. Endotoxins and other sepsis triggers Contrib Nephrol. 2010;167:14-24.
  33. Cani, PD; Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D et al. (2007). "Metabolic endotoxemia initiates obesity and insulin resistance.". Diabetes 56: 1761–1772.
  34. Kallus SJ, Brandt LJ. The intestinal microbiota and obesity. J Clin Gastroenterol. 2012;46:16-24.
  35. Ramachanrappa S and Farooqi I.S. Genetics approaches to understanding human obesity. Journal of Clinical investigation. 2011 121:2080-2086
  36. Tremblay A, Despres JP, Therault G, Fournier G, bouchard C. Overfeeding and energy expenditure in humans. Am J Clin Nutr 1993:56:857-62
  37. Bouchard C, Tremblay A, Després JP, Nadeau A, Lupien PJ, Thériault G, Dussault J, Moorjani S, Pinault S, Fournier G.The response to long-term overfeeding in identical twins. N Engl J Med. 1990 May 24;322(21):1477-82.
  38. Pontzer H, Raichlen DA, Wood BM, Mabulla AZ, Racette SB, Marlowe FW.Hunter-gatherer energetics and human obesity. PLoS One. 2012;7(7):e40503.
  39. Prentice AM, Black AE, Coward WA, Cole TJ. Energy expenditure in overweight and obese adults in affluent societies: an analysis of 319 doubly-labelled water measurements.Eur J Clin Nutr. 1996 Feb;50(2):93-7.
  40. Swinburn BA, Sacks G, Lo SK, Westerterp KR, Rush EC, Rosenbaum M, Luke A, Schoeller DA, DeLany JP, Butte NF, Ravussin E.Estimating the changes in energy flux that characterize the rise in obesity prevalence.Am J Clin Nutr. 2009 Jun;89(6):1723-8.
  41. Bäckhed, F.et al.The gut microbiota as an environmental factor that regulates fat storage. Proc. Natl Acad. Sci. USA 101, 15718–15723 (2004)
  42. Devillard, E., McIntosh, F. M., Duncan, S. H. & Wallace, R. J. Metabolism of linoleic acid by human gut bacteria: different routes for biosynthesis of conjugated linoleic acid. J. Bacteriol. 189, 2566–2570 (2007)
  43. Rossi M, Amaretti A, Raimondi S.Folate production by probiotic bacteria.Nutrients. 2011 Jan;3(1):118-34.
  44. Turnbaugh, P. J. et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444, 1027–1031 (2006).
  45. Le Chatelier E, et al. Richness of human gut microbiome correlates with metabolic markers.Nature. 2013 Aug 29;500(7464):541-6.
 Turnbaugh, P. J. et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444, 1027–1031 (2006)
  46. Goodman A.L., Kallstrom G, Faith J.J., Reyes A., et al. Extensive personal human gut microbiota culture collections characterized and manipulated in gnotobiotic mie. Proceddings of the national Academy of Sciences of the United States of America. 2010 108;346-357
  47. Dethlefsen, L., S. Huse, M. L. Sogin, and D. A. Relman. 2008. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol. 6:e280.
  48. Jakobsson HE et al Short-term antitioitc treatemtn ha differeing long-term impacts on the human throat and gut microbiome. PLoS ONE 5s, e9836 (2010).
  49. Jernberg C, Lofmark S, Edlund C, Jansson JK. Long-term ecological impacts of antibiotic administration on the human intestinal microbiota. ISME J. 1 56-66 (2007)
  50. Ajslev, T. A., Andersen, C. S., Gamborg, M., Sorensen, T. I. & Jess, T. Childhood overweight after establishment of the gut microbiota: the role of delivery mode, pre-pregnancy weight and early administration of antibiotics. Int. J. Obes. 35, 522–529 (2011)
  51. Duran GM, Marshall DL. Ready-to-eat shrimp as an international vehicle of antibiotic-resistant bacteria. J Food Prot. 2005 Nov;68(11):2395-401.
  52. Campos J, Mourão J, Pestana N, Peixe L, Novais C, Antunes P. Microbiological quality of ready-to-eat salads: an underestimated vehicle of bacteria and clinically relevant antibiotic resistance genes.Int J Food Microbiol. 2013 Sep 16;166(3):464-70.
  53. Brown JC, Jiang X. JPrevalence of antibiotic-resistant bacteria in herbal products. Food Prot. 2008 Jul;71(7):1486-90.
  54. Halden RU, Paull DH.Co-occurrence of triclocarban and triclosan in U.S. water resources.Environ Sci Technol. 2005 Mar 15;39(6):1420-6.
  55. Ternak G. Antibiotics may act as growth/obesity promoters in humans as an inadvertent result of antibiotic pollution? Med Hypotheses (2005)
  56. Moore PR, Evenson A, Luckey TD, McCoy E, Elvejem CA, Hart EB. Use of sulfasuxidine, streptothricin, and streptomycin in nutritional studies with the chick. J Biol Chem (1946) 165(2):437–41.
  57. Luecke RW, McMillen WN, Thorp F., Jr The effect of vitamin B12, animal protein factor and streptomycin on the growth of young pigs. Arch Biochem (1950) 26:326–7.
  58. Cho I, Yamanishi S, Cox L, Methe BA, Zavadil J, Li K, Gao Z, Mahana D, Raju K, Teitler I, et al. Antibiotics in early life alter the murine colonic microbiome and adiposity. Nature. 2012;488:621–626.
  59. Dethlefsen L, Relman DA. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc Natl Acad Sci U S A (2011) 108(Suppl 1):4554–61.
  60. Trasande L, Blustein J, Liu M, Corwin E, Cox LM, Blaser MJ. Infant antibiotic exposures and early-life body mass.Int J Obes (Lond). 2013 Jan;37(1):16-23.
  61. Thuny F, Richet H, Casalta JP, Angelakis E, Habib G, Raoult D. Vancomycin treatment of infective endocarditis is linked with recently acquired obesity. PLoS One (2010) 5(2):e9074.10.1371/journal.pone.0009074
  62. Wu GD, Chen J, Hoffmann C, Bittinger K, Chen YY, Keilbaugh SA, Bewtra M, Knights D, Walters WA, Knight R, Sinha R, Gilroy E, Gupta K, Baldassano R, Nessel L, Li H, Bushman FD, Lewis JD. Linking long-term dietary patterns with gut microbial enterotypes.Science. 2011 Oct 7;334(6052):105-8.
  63. Cotillard A, et al. Dietary intervention impact on gut microbial gene richness. Nature 500, 585–588 (29 August 2013)
  64. Duncan, S. H. et al. Reduced dietary intake of carbohydrates by obese subjects results in decreased concentrations of butyrate and butyrate-producing bacteria in feces. Appl. Environ. Microbiol. 73, 1073–1078 (2007)
Support